DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Prednisolone (Prednisolone) - Life Threatening Events - Suspected Cause - Side Effect Reports

 
 



Index of reports > Life Threatening Events (295)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Prednisolone life threatening events. The selected reports were submitted to the FDA during the sample period of about a year.

 Reports 1 - 30 of 295   Next >>

Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-08-27

Patient: female, weighing 39.7 kg (87.3 pounds)

Reactions: Scleroderma Renal Crisis, Posterior Reversible Encephalopathy Syndrome, Thrombotic Thrombocytopenic Purpura

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Prednisolone
    Dosage: 50 mg, unknown/d
    Administration route: Oral
    Indication: Dermatomyositis

Prednisolone
    Dosage: 13.75 mg, bid
    Administration route: Oral
    Start date: 2010-03-31

Prograf
    Indication: Scleroderma

Prograf
    Dosage: 2.5 mg, uid/qd
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2011-01-25
    End date: 2011-03-23

Other drugs received by patient: Amlodipine; Hirudoid; Procylin; Bonoteo; Itraconazole; Amlodipine; Omeprazole; Mobic; Pursennid; Antebate



Possible Prednisolone side effects in male

Reported by a physician from Australia on 2012-08-21

Patient: male, weighing 120.0 kg (264.0 pounds)

Reactions: Hepatosplenic T-Cell Lymphoma, Staphylococcal Sepsis

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Azathioprine Sodium
    Dosage: 2-2.5 mg/kg
    Start date: 1993-01-01
    End date: 1994-01-01

Azathioprine Sodium
    Indication: Crohn's Disease
    Start date: 1999-08-01
    End date: 2006-01-01

Prednisolone
    Dosage: varying doses
    Indication: Crohn's Disease
    Start date: 1993-01-01

Remicade
    Dosage: 3 infusions
    Indication: Crohn's Disease
    Start date: 1999-11-01
    End date: 2000-01-01



Possible Prednisolone side effects in female

Reported by a physician from Japan on 2012-08-20

Patient: female, weighing 47.7 kg (104.9 pounds)

Reactions: Cardio-Respiratory Arrest, Metabolic Acidosis, Hepatic Function Abnormal, Arthralgia, Disseminated Intravascular Coagulation, Platelet Count Decreased, Pyrexia, Device Related Infection, Septic Shock

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis

Remicade
    Indication: Rheumatoid Arthritis
    Start date: 2011-12-06

Remicade
    Start date: 2010-09-03

Remicade
    Dosage: 20th dose
    Start date: 2012-06-01

Remicade
    Start date: 2009-08-21

Other drugs received by patient: Folic Acid; Edirol; Lansoprazole; Cefazolin Sodium; Warfarin Sodium



Possible Prednisolone side effects in female

Reported by a physician from Netherlands on 2012-08-16

Patient: female, weighing 7.4 kg (16.3 pounds)

Reactions: Capillary Leak Syndrome, Hepatic Function Abnormal, Respiratory Failure, Disease Progression, Ascites

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 11 mg (40 mg/m2), qdx5
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Cyclophosphamide
    Dosage: 80 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Cytarabine
    Dosage: 15 mg, od
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-28
    End date: 2010-07-28

Cytarabine
    Indication: Chemotherapy

Etoposide
    Dosage: 28 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-23
    End date: 2010-07-27

Methotrexate
    Indication: Acute Lymphocytic Leukaemia

Methotrexate
    Dosage: 6 mgr, od
    Indication: Chemotherapy
    Start date: 2010-07-28
    End date: 2010-07-28

Prednisolone
    Indication: Chemotherapy

Prednisolone
    Dosage: 6 mgr, od
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2010-07-28
    End date: 2010-07-28

Other drugs received by patient: Itraconazole; Vancomycin; Dexamethasone; Filgrastim; Teicoplanin; Ciprofloxacin HCL; Ciprofloxacin HCL; Tramadol HCL; Vancomycin; Ceftazidime; Zofran; Vancomycin; Furosemide; Cotrim; Vancomycin; Vitamin K TAB; Cotrim; Itraconazole; Vancomycin; Vancomycin; Omeprazole; Acetaminophen; Ciprofloxacin; Furosemide; Ceftazidime; Furosemide; Omeprazole



Possible Prednisolone side effects in 76 year old male

Reported by a physician from Japan on 2012-08-10

Patient: 76 year old male

Reactions: Lung Squamous Cell Carcinoma Stage Unspecified

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Enbrel
    Dosage: 50 mg, weekly
    Start date: 2011-07-06

Enbrel
    Dosage: 20 mg, 2x/week
    Indication: Rheumatoid Arthritis
    Start date: 2011-03-18
    End date: 2011-07-01

Prednisolone
    Dosage: unk

Other drugs received by patient: Rimatil



Possible Prednisolone side effects in

Reported by a physician from United Kingdom on 2012-08-09

Patient:

Reactions: Small Intestinal Obstruction, Vomiting, Nausea, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1340 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Doxorubicin Hydrochloride
    Dosage: 90 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Prednisolone
    Dosage: 100 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Rituximab
    Dosage: 670 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Velcade
    Dosage: 2.3 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-30
    End date: 2012-06-08

Vincristine
    Dosage: 2 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Other drugs received by patient: Acyclovir; Allopurinol; Amitriptyline HCL; Omeprazole; Amitriptyline HCL; Metoclopramide; Metoclopramide



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-08-09

Patient: male, weighing 57.0 kg (125.4 pounds)

Reactions: Cytomegalovirus Hepatitis, Cytomegalovirus Enterocolitis, Cytomegalovirus Chorioretinitis, Pancytopenia

Adverse event resulted in: life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Cyclophosphamide
    Indication: Histiocytosis Haematophagic

Cyclophosphamide
    Dosage: 1200 milligram daily;
    Indication: B-Cell Lymphoma
    Start date: 2011-09-27
    End date: 2011-10-17

Cyclosporine
    Administration route: Oral
    Indication: Histiocytosis Haematophagic
    Start date: 2011-09-26

Doxorubicin HCL
    Indication: Histiocytosis Haematophagic
    Start date: 2011-09-27

Etoposide
    Indication: Histiocytosis Haematophagic
    Start date: 2011-09-13

Prednisolone
    Dosage: 60 milligram daily;
    Administration route: Oral
    Indication: B-Cell Lymphoma
    Start date: 2011-09-09
    End date: 2011-10-17

Prednisolone
    Indication: Histiocytosis Haematophagic

Rituximab
    Indication: Histiocytosis Haematophagic
    Start date: 2011-04-13

Rituximab
    Dosage: cycle 3 % 4
    Indication: B-Cell Lymphoma
    Start date: 2011-05-25

Treanda
    Indication: B-Cell Lymphoma
    Start date: 2011-04-13

Vincristine Sulfate
    Indication: Histiocytosis Haematophagic

Vincristine Sulfate
    Dosage: 2 milligram daily;
    Indication: B-Cell Lymphoma
    Start date: 2011-09-27

Other drugs received by patient: Pirarubicin Hydrochloride



Possible Prednisolone side effects in female

Reported by a individual with unspecified qualification from Japan on 2012-08-09

Patient: female, weighing 33.0 kg (72.6 pounds)

Reactions: Neutrophil Count Increased, Nausea, Diarrhoea, Sepsis, Asthenia, Decreased Appetite, Lymphocyte Count Decreased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: daily dosage unknown
    Administration route: Oral
    Start date: 2011-01-11
    End date: 2011-03-15

Temodal
    Start date: 2011-06-22
    End date: 2011-06-26

Temodal
    Start date: 2011-01-19
    End date: 2011-03-01

Temodal

Temodal
    Start date: 2011-04-14
    End date: 2011-04-18

Temodal
    Start date: 2011-07-19
    End date: 2011-07-23

Temodal
    Start date: 2011-03-17
    End date: 2011-03-21

Temodal
    Start date: 2011-05-16
    End date: 2011-05-20

Temozolomide
    Dosage: 150 mg/m2, qd
    Start date: 2011-03-17
    End date: 2011-03-21

Temozolomide
    Dosage: 200 mg/m2, qd
    Start date: 2011-04-14
    End date: 2011-07-23

Temozolomide
    Dosage: 75 mg/m2, qd
    Indication: Anaplastic Astrocytoma
    Start date: 2011-01-19
    End date: 2011-03-01

Other drugs received by patient: Sulfamethoxazole and Trimethoprim; Neuquinon; Neuquinon; Indomethacin; Cefazolin Sodium; Diovan; Lansoprazole; Magnesium Oxide; Granisetron; Diovan; Laxoberon; Simvastatin; Sulfamethoxazole and Trimethoprim; Neuquinon; Tegretol; Primperan TAB; Lorazepam; Prednisolone; Lansoprazole; Zolpidem; Simvastatin; Tegretol; Warfarin Sodium; Lorazepam; Urso 250; Warfarin Potassium; Warfarin Sodium



Possible Prednisolone side effects in male

Reported by a physician from Belgium on 2012-08-09

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: Shock Haemorrhagic, Splenic Lesion, Splenic Rupture

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 60 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-11
    End date: 2012-07-14

Prednisolone
    Dosage: 120 mg, qd
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-11



Possible Prednisolone side effects in 62 year old male

Reported by a physician from United Kingdom on 2012-08-08

Patient: 62 year old male, weighing 74.8 kg (164.6 pounds)

Reactions: Metastases To Central Nervous System, Pneumonitis

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Cabazitaxel
    Indication: Prostate Cancer
    Start date: 2012-03-08
    End date: 2012-03-08

Prednisolone
    Administration route: Oral
    Indication: Prostate Cancer
    Start date: 2012-03-08
    End date: 2012-03-09



Possible Prednisolone side effects in female

Reported by a health professional (non-physician/pharmacist) from Germany on 2012-08-06

Patient: female, weighing 66.0 kg (145.2 pounds)

Reactions: Osteoporotic Fracture, Pneumonia

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Indication: Chronic Myeloid Leukaemia
    Start date: 2003-09-08
    End date: 2011-07-04

Imatinib Mesylate
    Dosage: 400 mg, qd
    Administration route: Oral
    Start date: 2011-08-11

Prednisolone
    Dosage: unk
    Indication: Musculoskeletal Pain



Possible Prednisolone side effects in 69 year old female

Reported by a physician from Japan on 2012-08-06

Patient: 69 year old female

Reactions: Cerebral Infarction, Hypocalcaemia

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Administration route: Oral
    Indication: Interstitial Lung Disease

Ranmark
    Indication: Metastases To Bone
    Start date: 2012-05-01
    End date: 2012-05-01

Other drugs received by patient: Famotidine; Losartan Potassium; Clinoril; Anplag; Juvela N; Actonel; Epadel S



Possible Prednisolone side effects in

Reported by a physician from Korea, Republic of on 2012-08-02

Patient:

Reactions: Pneumonia, Neutropenia, Thrombocytopenia, Septic Shock

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 18 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Melphalan Hydrochloride
    Dosage: 11 mg/m2, unk
    Start date: 2012-03-22
    End date: 2012-03-25

Prednisolone
    Dosage: 58 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-01-30

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2012-01-27
    End date: 2012-04-01



Possible Prednisolone side effects in 77 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Blood Urea Increased, Pneumonia, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: 625 mg, qd
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-05-18

Exjade
    Dosage: 625 mg, on alternate days
    Administration route: Oral
    Start date: 2011-05-19

Exjade
    Dosage: 750 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-16
    End date: 2011-04-03

Prednisolone
    Dosage: 5 mg daily
    Administration route: Oral
    Start date: 2010-04-22

Prednisolone
    Dosage: 8 mg, daily
    Administration route: Oral
    End date: 2009-09-29

Prednisolone
    Dosage: 7 mg, daily
    Administration route: Oral
    Start date: 2009-09-30
    End date: 2010-02-02

Prednisolone
    Dosage: 6 mg, daily
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2010-04-21

Prednisolone
    Dosage: 4 mg, unk
    Administration route: Oral

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-04-12
    End date: 2011-05-02

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Other drugs received by patient: Equa; Xalatan; Desferal; Famotidine; Novolin R; RED Blood Cells, Concentrated; Glufast; Novolin R; RED Blood Cells, Concentrated; Alendronate Sodium; Timoptol-XE; Platelets; Novolin R; Amaryl; Novolin R; Azopt; Platelets; Famotidine; Glufast; Clarithromycin; Desferal; Desferal; Mucodyne; Voglibose



Possible Prednisolone side effects in 77 year old female

Reported by a physician from Japan on 2012-08-01

Patient: 77 year old female, weighing 36.0 kg (79.2 pounds)

Reactions: Blood Alkaline Phosphatase Increased, Back Pain, Pneumonia, Blood Urea Increased, Pubis Fracture, Urinary Tract Infection, General Physical Health Deterioration, Herpes Zoster, Renal Impairment, Sepsis, Dehydration, Neutropenia, Thrombocytopenia, Blood Creatinine Increased

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Exjade
    Dosage: 750 mg, qd
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2009-09-16
    End date: 2011-04-03

Exjade
    Dosage: 625 mg, on alternate days
    Administration route: Oral
    Start date: 2011-05-19

Exjade
    Dosage: 625 mg, qd
    Administration route: Oral
    Start date: 2011-05-07
    End date: 2011-05-18

Prednisolone
    Dosage: 8 mg, daily
    Administration route: Oral
    End date: 2009-09-29

Prednisolone
    Dosage: 7 mg, daily
    Administration route: Oral
    Start date: 2009-09-30
    End date: 2010-02-02

Prednisolone
    Dosage: 6 mg, daily
    Administration route: Oral
    Start date: 2010-02-03
    End date: 2010-04-21

Prednisolone
    Dosage: 4 mg, unk
    Administration route: Oral

Prednisolone
    Dosage: 5 mg daily
    Administration route: Oral
    Start date: 2010-04-22

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Indication: Myelodysplastic Syndrome
    Start date: 2011-04-12
    End date: 2011-05-02

Revlimid
    Dosage: 5 mg, daily
    Administration route: Oral
    Start date: 2011-05-19
    End date: 2011-06-01

Other drugs received by patient: Platelets; Novolin R; Clarithromycin; Xalatan; Desferal; Novolin R; RED Blood Cells, Concentrated; Mucodyne; Famotidine; Famotidine; Azopt; Platelets; Desferal; RED Blood Cells, Concentrated; Alendronate Sodium; Voglibose; Timoptol-XE; Amaryl; Novolin R; Novolin R; Glufast; Glufast; Desferal; Equa



Possible Prednisolone side effects in 70 year old male

Reported by a physician from Japan on 2012-07-31

Patient: 70 year old male, weighing 60.0 kg (132.0 pounds)

Reactions: Coronary Artery Stenosis

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Orencia
    Indication: Rheumatoid Arthritis
    Start date: 2012-05-29

Prednisolone
    Administration route: Oral
    Indication: Rheumatoid Arthritis
    Start date: 2012-05-17

Other drugs received by patient: Rheumatrex



Possible Prednisolone side effects in male

Reported by a physician from Belgium on 2012-07-31

Patient: male, weighing 81.0 kg (178.2 pounds)

Reactions: Shock Haemorrhagic, Splenic Lesion, Splenic Rupture

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Clofarabine
    Dosage: 60 mg, qd
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-11
    End date: 2012-07-14

Prednisolone
    Dosage: 120 mg, qd
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2012-07-11



Possible Prednisolone side effects in

Reported by a physician from United Kingdom on 2012-07-30

Patient:

Reactions: Small Intestinal Obstruction, Vomiting, Nausea, Abdominal Pain Upper

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Dosage: 1340 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Doxorubicin Hydrochloride
    Dosage: 90 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Prednisolone
    Dosage: 100 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Rituximab
    Dosage: 670 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Velcade
    Dosage: 2.3 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-30
    End date: 2012-06-08

Vincristine
    Dosage: 2 mg, unk
    Indication: B-Cell Lymphoma
    Start date: 2012-05-11
    End date: 2012-05-30

Other drugs received by patient: Omeprazole; Metoclopramide; Amitriptyline Hydrochloride; Allopurinol; Amitriptyline Hydrochloride; Metoclopramide; Acyclovir



Possible Prednisolone side effects in

Reported by a consumer/non-health professional from Japan on 2012-07-27

Patient:

Reactions: Neutrophil Count Increased, Diarrhoea, Nausea, Sepsis, Asthenia, Lymphocyte Count Decreased, Decreased Appetite

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: daily dosage unknown
    Administration route: Oral
    Start date: 2011-01-11
    End date: 2011-03-15

Temodal
    Start date: 2011-05-16
    End date: 2011-05-20

Temodal
    Start date: 2011-07-19
    End date: 2011-07-23

Temodal
    Start date: 2011-06-22
    End date: 2011-06-26

Temodal
    Start date: 2011-01-19
    End date: 2011-03-01

Temodal
    Start date: 2011-03-17
    End date: 2011-03-21

Temodal
    Start date: 2011-04-14
    End date: 2011-04-18

Temodal

Temozolomide
    Dosage: 75 mg/m2, qd
    Indication: Anaplastic Astrocytoma
    Start date: 2011-01-19
    End date: 2011-03-01

Temozolomide
    Dosage: 150 mg/m2, qd
    Start date: 2011-03-17
    End date: 2011-03-21

Temozolomide
    Dosage: 200 mg/m2, qd
    Start date: 2011-04-14
    End date: 2011-07-23

Other drugs received by patient: Warfarin Sodium; Warfarin Potassium; Laxoberon; Granisetron; Tegretol; Indomethacin; Warfarin Sodium; Neuquinon; Neuquinon; Neuquinon; Lorazepam; Magnesium Oxide; Sulfamethoxazole and Trimethoprim; Diovan; Lorazepam; Tegretol; Urso 250; Zolpidem; Diovan; Simvastatin; Prednisolone; Cefazolin Sodium; Lansoprazole; Sulfamethoxazole and Trimethoprim; Lansoprazole; Primperan TAB; Simvastatin



Possible Prednisolone side effects in 8 year old male

Reported by a health professional (non-physician/pharmacist) from Saudi Arabia on 2012-07-25

Patient: 8 year old male

Reactions: Gingival Bleeding, Stridor, Graft Versus Host Disease, Kaposi's Sarcoma, Gingival Hypertrophy, Pulmonary Mass, Graft Versus Host Disease in Liver, Oral Mucosal Exfoliation, Rash Macular, Bone Marrow Disorder, Lung Consolidation, Respiratory Failure, Acute Graft Versus Host Disease in Skin, Graft Versus Host Disease in Intestine, Pneumothorax, Lung Infiltration

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Busulfex
    Dosage: 16 mg/kg, intravenous
    Indication: Bone Marrow Conditioning Regimen

Cyclophosphamide
    Dosage: 200 mg/kg, intravenous
    Indication: Bone Marrow Conditioning Regimen

Cyclosporine
    Indication: Prophylaxis Against Graft Versus Host Disease

Prednisolone
    Dosage: 4 mg/kg, daily dose
    Indication: Graft Versus Host Disease



Possible Prednisolone side effects in 50 year old female

Reported by a physician from Japan on 2012-07-24

Patient: 50 year old female, weighing 69.0 kg (151.8 pounds)

Reactions: Neutrophil Count Increased, Rhinitis Allergic, Insomnia, Platelet Count Decreased, Headache, Acute Myocardial Infarction

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Prednisolone
    Dosage: 11 mg, unk
    Administration route: Oral
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-08-27

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Start date: 2012-03-07
    End date: 2012-04-11

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Start date: 2011-10-06
    End date: 2011-10-06

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Start date: 2011-10-12
    End date: 2011-11-16

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Indication: Idiopathic Thrombocytopenic Purpura
    Start date: 2011-09-20
    End date: 2011-09-27

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Start date: 2011-11-24
    End date: 2012-02-29

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Start date: 2012-04-18
    End date: 2012-05-09

Romiplostim - KHK
    Dosage: 3.57 mug/kg, qwk
    Start date: 2012-05-17
    End date: 2012-05-30

Other drugs received by patient: Lendormin; Lansoprazole; Acetaminophen; Pursennid; Mucosta; Alendronate Sodium; Rozerem



Possible Prednisolone side effects in 81 year old female

Reported by a health professional (non-physician/pharmacist) from Norway on 2012-07-24

Patient: 81 year old female

Reactions: Anaemia, Gastric Ulcer, Gastric Haemorrhage

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis

Prednisolone
    Administration route: Oral
    Indication: Musculoskeletal Stiffness

Other drugs received by patient: Calcigran Forte; Adalat; Atenolol



Possible Prednisolone side effects in female

Reported by a consumer/non-health professional from United Kingdom on 2012-07-23

Patient: female, weighing 67.0 kg (147.4 pounds)

Reactions: Small Intestinal Obstruction, Anaemia, Febrile Neutropenia, Device Related Infection

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Cyclophosphamide
    Start date: 2012-04-26

Doxorubicin HCL
    Start date: 2012-04-26

Prednisolone
    Administration route: Oral
    Start date: 2012-04-26

Vincristine
    Start date: 2012-04-26



Possible Prednisolone side effects in 66 year old male

Reported by a physician from Japan on 2012-07-20

Patient: 66 year old male

Reactions: Pneumonia, Interstitial Lung Disease

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Start date: 2010-12-22
    End date: 2010-12-22

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-10-14
    End date: 2010-10-14

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-11-24
    End date: 2010-11-24

Adriamycin PFS
    Dosage: 30 mg/m2, unk
    Start date: 2010-12-29
    End date: 2010-12-29

Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Start date: 2010-11-16
    End date: 2010-11-16

Adriamycin PFS
    Dosage: 40 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-10-07

Allopurinol
    Dosage: 100 mg, 3x/day
    Administration route: Oral
    Start date: 2011-07-05
    End date: 2011-07-19

Allopurinol
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Hyperuricaemia
    End date: 2011-01-20

Amlodipine
    Dosage: 5 mg, 1x/day
    Administration route: Oral
    Indication: Hypertension
    Start date: 2010-10-08
    End date: 2011-02-17

Baraclude
    Dosage: 0.5 mg, 1/2day
    Administration route: Oral
    Indication: Hepatitis B
    Start date: 2010-06-29
    End date: 2011-07-19

Carboplatin
    Dosage: 250 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

Cefazolin Sodium
    Dosage: unk
    Administration route: Oral
    Indication: Proctitis
    Start date: 2010-10-22
    End date: 2011-02-17

Cyclophosphamide
    Dosage: 350 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-22

Cymerin
    Dosage: 60 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-14
    End date: 2010-12-29

Cytarabine
    Dosage: 40 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Diflucan
    Dosage: 100 mg, 1x/day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    End date: 2011-01-11

Diflucan
    Dosage: unk
    Start date: 2011-01-19
    End date: 2011-01-28

Etoposide
    Dosage: 100 mg/m2, 3x/day
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

Fentanyl
    Dosage: unk
    Indication: Stomatitis
    Start date: 2011-01-02
    End date: 2011-01-19

Fildesin
    Dosage: 2.4 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-26
    End date: 2010-12-08

KW-0761
    Dosage: 1 mg/kg, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-08
    End date: 2010-12-21

Lansoprazole
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-07-19

Lansoprazole
    Dosage: 15 mg, 1x/day
    Administration route: Oral
    Indication: Gastrooesophageal Reflux Disease
    End date: 2011-02-17

Lipidil
    Dosage: 100 df, 1x/day
    Administration route: Oral
    Indication: Hyperlipidaemia
    End date: 2011-01-26

Lyrica
    Dosage: 75 mg, 1x/day
    Administration route: Oral
    Indication: Pain
    Start date: 2011-06-29
    End date: 2011-07-19

Magmitt
    Dosage: unk
    Administration route: Oral
    Indication: Constipation
    Start date: 2011-01-07
    End date: 2011-01-10

Meropenem
    Dosage: 0.5 g, 2x/day
    Indication: Pneumonia
    Start date: 2011-01-07
    End date: 2011-01-24

Meropenem
    Dosage: 1 g, 3x/day
    Start date: 2011-07-04
    End date: 2011-07-15

Methotrexate Sodium
    Dosage: 15 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Oncovin
    Dosage: 1 mg/m2, unk
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-22

Pantosin
    Dosage: unk
    Administration route: Oral
    Indication: Constipation
    Start date: 2011-01-07
    End date: 2011-01-10

Prednisolone
    Dosage: 40 mg/m2, unk
    Administration route: Oral
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-10-07
    End date: 2010-12-29

Prednisolone
    Dosage: 10 mg, daily
    Indication: Adult T-Cell Lymphoma / Leukaemia
    Start date: 2010-11-18
    End date: 2010-11-18

Sulfamethoxazole and Trimethoprim
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Start date: 2011-07-15

Sulfamethoxazole and Trimethoprim
    Dosage: 1 df, 1x/day
    Administration route: Oral
    Indication: Antifungal Prophylaxis
    End date: 2011-01-28

Vancomycin
    Dosage: 0.5 g, 2x/day
    Start date: 2011-01-07
    End date: 2011-01-17

Zovirax
    Dosage: unk
    Start date: 2011-06-30
    End date: 2011-07-08

Zovirax
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Indication: Prophylaxis
    End date: 2011-01-28

Zovirax
    Dosage: 200 mg, 1x/day
    Administration route: Oral
    Start date: 2011-07-12
    End date: 2011-07-19

Other drugs received by patient: Vfend; Targocid; Slow-K; Ciprofloxacin HCL



Possible Prednisolone side effects in 70 year old female

Reported by a physician from Japan on 2012-07-19

Patient: 70 year old female

Reactions: Myelodysplastic Syndrome

Adverse event resulted in: life threatening event

Drug(s) suspected as cause:
Cladribine
    Dosage: 03 courses
    Start date: 2008-06-17
    End date: 2008-08-21

Cladribine
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Cyclophosphamide
    Dosage: 01 course
    Start date: 2008-05-20
    End date: 2008-05-24

Doxorubicin Hydrochloride
    Dosage: 01 course
    Indication: Product Used FOR Unknown Indication
    Start date: 2008-05-20
    End date: 2008-05-24

Ibritumomab Tiuxetan
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication
    Start date: 2009-04-08

Mabthera
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Mabthera
    Dosage: 08 courses
    Start date: 2008-07-11
    End date: 2008-12-02

Mabthera
    Dosage: 03 courses
    Start date: 2007-01-11
    End date: 2007-01-25

Mitoxantrone Hydrochloride
    Dosage: 03 courses
    Start date: 2008-06-17
    End date: 2008-08-21

Mitoxantrone Hydrochloride
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Prednisolone
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication

Prednisolone
    Dosage: 01 course
    Start date: 2008-05-20
    End date: 2008-05-24

Vincristine Sulfate
    Dosage: 01 course
    Start date: 2008-05-20
    End date: 2008-05-24

Vincristine Sulfate
    Dosage: unknown
    Indication: Product Used FOR Unknown Indication



Possible Prednisolone side effects in male

Reported by a physician from Japan on 2012-07-18

Patient: male

Reactions: Bronchopneumonia, Disseminated Intravascular Coagulation, Pyrexia, Constipation, Herpes Zoster, Neuropathy Peripheral, C-Reactive Protein Increased, Thrombocytopenia, Blood Creatinine Increased, Cardiac Failure Congestive, Decreased Appetite, Prothrombin Time Ratio Increased, Dyspnoea, Pneumonia, Anaemia, Muscular Weakness, Lobar Pneumonia, Haemoglobin Decreased, Cerebral Infarction, Sepsis, Platelet Count Decreased, Neutropenia, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization, disablity

Drug(s) suspected as cause:
Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Start date: 2012-01-13
    End date: 2012-02-03

Dexamethasone
    Dosage: 2.8571 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-12-10
    End date: 2012-01-07

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-05-12
    End date: 2011-05-25

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-05-26
    End date: 2011-06-01

Prednisolone
    Dosage: 10 milligram
    Indication: Multiple Myeloma
    Start date: 2012-02-09
    End date: 2012-02-17

Prednisolone
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-03-31
    End date: 2011-04-13

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-03-30

Prednisolone
    Dosage: 10 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2012-02-08

Prednisolone
    Dosage: 60 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Indication: Multiple Myeloma
    Start date: 2011-03-24
    End date: 2011-04-13

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-08-17
    End date: 2011-09-06

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-09-14
    End date: 2011-10-03

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-10-12
    End date: 2011-10-22

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2011-12-11
    End date: 2011-12-31

Revlimid
    Dosage: 15 milligram
    Administration route: Oral
    Start date: 2011-04-21
    End date: 2011-05-11

Revlimid
    Dosage: 5 milligram
    Administration route: Oral
    Start date: 2012-01-25
    End date: 2012-02-11

Other drugs received by patient: Glufast; Warfarin Sodium; Famotidine; Mucosta; Flomax; Warfarin Sodium; Magnesium Oxide; Zometa; Lansoprazole; Magnesium Oxide; Slow-K; Glufast; Tamsulosin HCL; Humulin R; Warfarin Sodium; Tamsulosin HCL; SHA-Kanzo-TO; SHA-Kanzo-TO; Levothyroxine Sodium; Diovan; Slow-K; Warfarin Sodium; Mucosta; Diovan; Clarithromycin; Levothyroxine Sodium; Levothyroxine Sodium; Zometa



Possible Prednisolone side effects in female

Reported by a physician from Norway on 2012-07-18

Patient: female

Reactions: Anaemia, Gastric Ulcer, Gastric Haemorrhage

Adverse event resulted in: life threatening event, hospitalization

Drug(s) suspected as cause:
Alendronate Sodium
    Administration route: Oral
    Indication: Osteoporosis

Prednisolone
    Administration route: Oral
    Indication: Musculoskeletal Stiffness

Other drugs received by patient: Calcigran Forte; Atenolol; Adalat



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Disseminated Intravascular Coagulation, Enterococcal Infection, Coagulopathy, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Pneumocystis Jiroveci Pneumonia, Anal Fistula, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Gastrointestinal Ulcer Haemorrhage, Restlessness, Hyperglycaemia, Anaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Large Intestinal Ulcer, Ileal Fistula, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Anal Haemorrhage, Purulence, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in male

Reported by a health professional (non-physician/pharmacist) from Japan on 2012-07-18

Patient: male

Reactions: Gastrointestinal Haemorrhage, Coagulopathy, Disseminated Intravascular Coagulation, Enterococcal Infection, Cardiac Failure Acute, Pneumonia Cytomegaloviral, Anal Fistula, Pneumocystis Jiroveci Pneumonia, Colonic Fistula, Acute Respiratory Distress Syndrome, Circulatory Collapse, Apnoea, Melaena, Cytomegalovirus Enterocolitis, Metabolic Acidosis, Restlessness, Gastrointestinal Ulcer Haemorrhage, Anaemia, Hyperglycaemia, Duodenal Ulcer, Ulcer, Delirium, Fungal Infection, Insomnia, Systemic Inflammatory Response Syndrome, Septic Shock, Hypoventilation, Oral Administration Complication, Shock Haemorrhagic, Ileal Ulcer, Interstitial Lung Disease, Ileal Fistula, Large Intestinal Ulcer, Small Intestinal Haemorrhage, Acute Respiratory Failure, Dyspnoea, Diarrhoea, Respiratory Failure, Sepsis, Purulence, Anal Haemorrhage, Hypertension

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Bredinin
    Dosage: 100 mg, daily
    Administration route: Oral
    End date: 2011-03-08

Mycophenolate Mofetil
    Indication: Renal Transplant

Neoral
    Dosage: 50 mg, daily
    Administration route: Oral
    Indication: Renal Transplant
    End date: 2011-03-15

Neoral
    Dosage: 100 mg, daily
    Administration route: Oral
    Start date: 2010-11-18
    End date: 2011-03-15

Prednisolone
    Dosage: 10 mg, daily
    Administration route: Oral
    End date: 2011-03-18

Prednisolone
    Dosage: 10 mg, unk
    End date: 2011-03-22

Prograf
    Dosage: 2 mg, daily
    Administration route: Oral
    End date: 2011-11-17

Rituximab
    Dosage: unk ukn, unk

Other drugs received by patient: Insulin



Possible Prednisolone side effects in

Reported by a physician from Korea, Republic of on 2012-07-16

Patient:

Reactions: Cerebral Haemorrhage

Adverse event resulted in: death, life threatening event

Drug(s) suspected as cause:
Melphalan Hydrochloride
    Dosage: 9 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-10-07
    End date: 2011-10-08

Prednisolone
    Dosage: 60 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-10-07
    End date: 2011-10-10

Velcade
    Dosage: 1.0 mg/m2, unk
    Start date: 2011-10-26
    End date: 2011-10-26

Velcade
    Dosage: 1.3 mg/m2, unk
    Indication: Multiple Myeloma
    Start date: 2011-10-07
    End date: 2011-10-07

Velcade
    Dosage: 1.0 mg/m2, unk
    Start date: 2011-10-19
    End date: 2011-10-19

Velcade
    Dosage: 0.7 mg/m2, unk
    Start date: 2002-10-23
    End date: 2011-10-23

Other drugs received by patient: Dextrose



 Page 1   Next >>

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017